Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA
- 9 January 2011
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 151 (2), 149-154
- https://doi.org/10.1016/j.jconrel.2010.12.013
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexesJournal of Controlled Release, 2010
- Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM productionJournal of Controlled Release, 2009
- Lipid-based systemic delivery of siRNAAdvanced Drug Delivery Reviews, 2009
- Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in miceJournal of Clinical Investigation, 2009
- Comparison of human B cell activation by TLR7 and TLR9 agonistsBMC Immunology, 2008
- Nonviral delivery of synthetic siRNAs in vivoJournal of Clinical Investigation, 2007
- Transvascular delivery of small interfering RNA to the central nervous systemNature, 2007
- Gene Expression Analysis in Blood Cells in Response to Unmodified and 2′-Modified siRNAs Reveals TLR-dependent and Independent EffectsJournal of Molecular Biology, 2007
- Improved formulations of antisense oligodeoxynucleotides using wrapped liposomesJournal of Controlled Release, 2006
- Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationJournal of Molecular Biology, 2005